Skip to content
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Clinical Topics
View All
Addiction
Anxiety
Bipolar Disorder
Depression
Difficult to Treat Depression
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Auvelity: Information from Industry
Banner Alzheimer’s Institute
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
Rounds in the General Hospital
Ella J. Daly, MD
JCP
Original Research
Esketamine Nasal Spray and Adverse Events Over Time
September 19, 2022
This study looked at the occurrence and severity of adverse events over time with esketamine nasal spray in MDD patients also receiving an oral antidepressant.
David J. Williamson
,
Jagadish P. Gogate
,
Jennifer K. Kern Sliwa
, et al
JCP
Original Research
Esketamine Nasal Spray Plus for Depression
April 28, 2020
Read a study about esketamine nasal spray (oral antidepressant) and it's long-term safety, tolerability, and efficacy for treatment-resistant depression (TRD).
Ewa Wajs
,
Leah Aluisio
,
Richard Holder
, et al
PCC
Original Research
A Computerized Decision Support System for Depression in Primary Care
August 19, 2009
Benji T. Kurian
,
Madhukar H. Trivedi
,
Bruce D. Grannemann
, et al
